Literature DB >> 17316896

Daptomycin-resistant Enteroccoccus faecium in a patient with no prior exposure to daptomycin.

M H Fraher, G D Corcoran, S Creagh, E Feeney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17316896     DOI： 10.1016/j.jhin.2007.01.002

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN： 0195-6701            Impact factor:   3.926


× No keyword cloud information.
  10 in total

1.  Emergence of daptomycin-resistant VRE: experience of a single institution.

Authors:  Mini Kamboj; Nina Cohen; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

2.  Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds.

Authors:  Sebastian Schmidt; Markus M Heimesaat; André Fischer; Stefan Bereswill; Matthias F Melzig
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-12-16

Review 3.  A potential role for daptomycin in enterococcal infections: what is the evidence?

Authors:  Rafael Cantón; Patricia Ruiz-Garbajosa; Ricardo L Chaves; Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2010-04-02       Impact factor: 5.790

4.  A mutation in the glycosyltransferase gene lafB causes daptomycin hypersusceptibility in Enterococcus faecium.

Authors:  Suelen S Mello; Daria Van Tyne; Francois Lebreton; Simone Q Silva; Mara C L Nogueira; Michael S Gilmore; Ilana L B C Camargo
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

5.  Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.

Authors:  Truc T Tran; Diana Panesso; Hongyu Gao; Jung H Roh; Jose M Munita; Jinnethe Reyes; Lorena Diaz; Elizabeth A Lobos; Yousif Shamoo; Nagendra N Mishra; Arnold S Bayer; Barbara E Murray; George M Weinstock; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191

6.  Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.

Authors:  Lynn El Haddad; Blake M Hanson; Cesar A Arias; Shashank S Ghantoji; Cynthia P Harb; Mark Stibich; Roy F Chemaly
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

7.  De novo daptomycin-nonsusceptible enterococcal infections.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David Pegues
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 16.126

8.  Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians.

Authors:  Theodoros Kelesidis; Romney Humphries; Daniel Z Uslan; David A Pegues
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 20.999

9.  Vancomycin-resistant enterococci with reduced daptomycin susceptibility in Singapore: prevalence and associated factors.

Authors:  A Chow; N N Win; P Y Ng; W Lee; M K Win
Journal:  Epidemiol Infect       Date:  2016-05-13       Impact factor: 4.434

10.  Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Authors:  Jeremy C Storm; Daniel J Diekema; Jennifer S Kroeger; Sarah J Johnson; Birgir Johannsson
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-29       Impact factor: 4.887
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.